# A Study of PM1022 in Patients With Advanced Tumors

> **NCT05867771** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Biotheus Inc.** · enrollment: 200 (estimated)

## Conditions studied

- Advanced Tumors

## Interventions

- **DRUG:** PM1022

## Key facts

- **NCT ID:** NCT05867771
- **Lead sponsor:** Biotheus Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-11
- **Primary completion:** 2024-04-10
- **Final completion:** 2025-04-10
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2023-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05867771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05867771, "A Study of PM1022 in Patients With Advanced Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05867771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*